Microgen develops, manufactures, and markets novel in-vitro research products for biomedical research. In addition, Microgen provides microbial and molecular genetic services. The company technology is based on proprietary and patented technologies applied to several areas such as:

• Detection of rare (i.e., cancer) cell events
• Detection and identification of infectious disease pathogens
• Drug / toxicity screening

Customers for the company's products include clinicians and researchers in industrial, academic, and government laboratories.